Optimization of a methamphetamine conjugate vaccine for antibody production in mice

about

Pharmacotherapeutic agents in the treatment of methamphetamine dependence.Conjugate Vaccine Immunotherapy for Substance Use Disorder.

P2860

Q30235058-B3EDFDE0-DB09-48D7-BF70-498CEE5D6004 Q39387013-8E63EA86-3A9F-4BEC-AEA4-8022EE4E937B

P2860

Optimization of a methamphetamine conjugate vaccine for antibody production in mice

Item

http://www.wikidata.org/entity/Q36854009

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Optimization of a methamphetamine conjugate vaccine for antibody production in mice

@en

type

Item

label

Optimization of a methamphetamine conjugate vaccine for antibody production in mice

@en

prefLabel

Optimization of a methamphetamine conjugate vaccine for antibody production in mice

@en

P1476

Optimization of a methamphetamine conjugate vaccine for antibody production in mice

@en

P2093

Melinda G Gunnell

http://www.w3.org/2001/XMLSchema#string

Misty W Stevens

http://www.w3.org/2001/XMLSchema#string

Rachel Tawney

http://www.w3.org/2001/XMLSchema#string

P2860

Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant

Novel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten Carrier

A synthetic adjuvant to enhance and expand immune responses to influenza vaccines

Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant.

The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse.

Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic

Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells

Simple radiometric method for accurately quantitating epitope densities of hapten-protein conjugates with sulfhydryl linkages.

Impact of distinct chemical structures for the development of a methamphetamine vaccine

Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines.

P304

137-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.INTIMP.2016.03.028

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

S Michael Owens

P577

2016-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27039212

http://www.w3.org/2001/XMLSchema#string

P932

4851881

http://www.w3.org/2001/XMLSchema#string

Optimization of a methamphetamine conjugate vaccine for antibody production in mice

about

P2860

P2860

Optimization of a methamphetamine conjugate vaccine for antibody production in mice

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932